Caxton Associates (New York)’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-73,061
| Closed | -$923K | – | 615 |
|
|
2024
Q3 | $923K | Buy |
+73,061
| New | +$923K | 0.03% | 255 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 526 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 538 |
|
|
2020
Q3 | – | Sell |
-2,940
| Closed | -$245K | – | 442 |
|
|
2020
Q2 | $245K | Buy |
+2,940
| New | +$245K | 0.02% | 306 |
|